Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Oct 23 2013
Washington, D.C. (October 17, 2013) – The Biotechnology Industry Organization (BIO) announced today that veteran Congressional and campaign...
Oct 23 2013
Washington, D.C. (October 17, 2013) – The Biotechnology Industry Organization (BIO) announced today that veteran Congressional and campaign...
Oct 23 2013
Washington, D.C. (October 23, 2013) – The Biotechnology Industry Organization (BIO) applauds key Members of the House of Representatives for holding...
Oct 22 2013
Indianapolis, IN (October 22, 2013) – Fritz Bittenbender, Senior Vice President, External Affairs, Biotechnology Industry Organization, testified today...
Oct 21 2013
Washington, D.C. (October 21, 2013) – The Biotechnology Industry Organization (BIO) today announces that the BIO International Convention – the...
Oct 18 2013
The Biotechnology Industry Organization (BIO) today condemned the American Petroleum Institute’s (API) Notice of Intent to File Citizen Suit against...
Oct 18 2013
J. Craig Venter to deliver keynote: “Life at the Speed of Light” Washington, D.C. (October 18, 2013) –Biotechnology innovations and...
Oct 14 2013
Washington, D.C. (October 14, 2013) - The Biotechnology Industry Organization (BIO) is pleased to announce that Washington State Gov. Jay Inslee will provide...
Oct 13 2013
Washington, D.C. (October 13, 2013) –  The Biotechnology Industry Organization (BIO) is disappointed to learn that California Governor Jerry Brown...


Biotechnology News

August 29, 2014

PARIS--(BUSINESS WIRE)--Regualtory News: The Board of Directors of Ipsen (Euronext: IPN; ADR: IPSEY), chaired by Marc de Garidel, met on 28 August 2014 to approve the...

August 28, 2014

TOKYO--(BUSINESS WIRE)--BioJapan 2014 – World Business Forum – will be held for three days from October 15th (Wed.) to 17th (Fri.), 2014 at Pacifico Yokohama (Exhibition...

August 28, 2014

BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix (Nasdaq: OCUL), announced financial results for the second quarter ended June 30, 2014.

August 28, 2014

EDMONTON, Alberta--(BUSINESS WIRE)--Radient Technologies Inc. (TSX-V:RTI) (the “Corporation”) announced today that it has released its financial results for the first...

August 28, 2014

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences will participate in Baird’s 2014 Health Care Conference Thursday, Sept. 4 in New York.